Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

NCT01212380 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

B-cell Chronic Lymphocytic Leukemia
Hematopoietic/Lymphoid Cancer
Prolymphocytic Leukemia
Recurrent Small Lymphocytic Lymphoma
Refractory Chronic Lymphocytic Leukemia

Interventions

DRUG: carfilzomib
OTHER: Cytokine Assessment
OTHER: Pharmacodynamic Studies
OTHER: Proteosome Inhibition Assessment
OTHER: Pharmacogenomic Studies

Sponsor

Ohio State University Comprehensive Cancer Center

Collaborators

[object Object]